Moubayed NM, Bhat RS, Al Farraj D, Dihani NA, El Ansary A, Fahmy RM
Ozempic The argument that cholesterol and cardiovascular event reduction is an effect of GLP-1 agonists is strengthened by studies that led the FDA to grant similar approval for cardiovascular event risk reduction to other GLP-1 medications
If your unopened pen was left out overnight, the UK product information does not provide specific guidance on temporary unrefrigerated storage, so it's safest to consult your pharmacist or GP for advice
GLP-1 receptor agonists are contraindicated in patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2
For information on solution quality indicators, our peptide safety guide explains what to look for
We invite you to take our free assessment quiz to see if you qualify for our prescription weight loss medications